NuVasive Launches TLX 20 Expandable Interbody

NuVasive (NUVA) continues to broaden its expandable portfolio with launch of the TLX® 20 degree expandable spinal interbody implant for transforaminal lumbar interbody fusion (TLIF).

Prior to TLX 20 receiving FDA 510(k) clearance in 4Q17, TLX interbodies were available in 15° lordotic options and only indicated for use with allograft. New...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us